Public Company News

Gan & Lee Pharmaceuticals Begins First-In-Human Trial in U.S. for Investigational Drug, GZR18

BEIJING and BRIDGEWATER, N.J., March 11, 2022 /PRNewswire/ -- Gan & Lee Pharmaceuticals Co., Ltd. (hereinafter referred to as Gan & Lee, stock code: 603087.SH), is pleased to announce the first subject has been dosed in our Phase I, double-blinded, randomized, placebo-controlled, sequential, sing...

2022-03-11 03:35 4929

Novavax Announces Launch of Global Vaccine Education Programs

-  'We Do Vaccines' and 'Know Our Vax' are new educational efforts that provide information regarding vaccines -  Programs explain Novavax' commitment to vaccine development and innovation GAITHERSBURG, Md., March 10, 2022 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company de...

2022-03-10 22:00 5498

Bigtincan Wins Silver Stevie® Award for its Sales Enablement Solution

Leader in sales enablement automation takes home 7th Stevie Award for Sales & Customer Service WALTHAM, Mass., March 10, 2022 /PRNewswire/ -- Bigtincan (ASX: BTH), the global leader in sales enablement automation, today announced the company has won a Silver 2022 Stevie® Award for the Sales Enab...

2022-03-10 21:00 3786

BNY Mellon Announces Leadership Succession Plan Naming Robin Vince CEO-Elect

CEO Todd Gibbons to Retire This Year Robin Vince, Vice Chair of BNY Mellon and CEO of Global Market Infrastructure, Named President and CEO-elect NEW YORK, March 10, 2022 /PRNewswire/ -- The Bank of New York Mellon Corporation ("BNY Mellon") (NYSE: BK) announced today thatThomas P. (Todd) Gibbo...

2022-03-10 20:30 6300

Infineon and Sleepiz enable high-precision sleep monitoring at home based on radar technology

MUNICH, March 10, 2022 /PRNewswire/ -- Billions of people are facing sleep problems. According to scientific research[1], about one billion people alone suffer from sleep apnea, an interrupted breathing during the night. This is leading to various health consequences including snoring, daytime fa...

2022-03-10 19:49 5358

Everest Medicines Announces that Licensing Partner Venatorx Pharmaceuticals Reports Positive Results from Pivotal Phase 3 Cefepime-Taniborbactam Trial

SHANGHAI, March 10, 2022 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK) announced today that its licensing partner, Venatorx Pharmaceuticals, reported positive results from its pivotal Phase 3 study, CERTAIN-1 (Cefepime Rescue with Taniborbactam in cUTI), evaluating cefepime-taniborbactam, an in...

2022-03-10 19:05 4883

Infosys Becomes Digital Innovation Partner for International Tennis Hall of Fame and Title Sponsor of the Hall of Fame Open

Strategic collaboration to bring technology expertise to reimagine fan experiences and preserve tennis heritage at the historic venue where the first U.S. National Championships were hosted in 1881 NEWPORT, R.I., March 10, 2022 /PRNewswire/ -- Infosys  (NSE: INFY) (BSE:...

2022-03-10 18:49 4084

Fosun Foundation's Second Batch of More Than 500,000 Pieces of Anti-epidemic Materials Arrives in Hong Kong Successively to Aid High-risk Groups and Grassroots Families

HONG KONG, March 10, 2022 /PRNewswire/ -- In the face of the severe fifth wave of epidemic inHong Kong, Fosun Foundation quickly launched the epidemic relief work of "Let's Work Hand in Hand and Combat the Epidemic Together" inHong Kong. After the first batch of 250,000 sets of COVID-19 rapid ant...

2022-03-10 14:25 4312

GOODWE CHANGES BRAND GUIDELINE WITH MORE COOPERATION OPPORTUNITIES

HANOI, Vietnam, March 10, 2022 /PRNewswire/ -- On January 7, 2022, GoodWe, the world's leading manufacturer of energy storage solutions and solar inverters, officially changed its brand identity to match the development trend of the renewable energy industry. The core of the rebranding is GoodWe'...

2022-03-10 13:15 4823

SleekFlow, an Alibaba-backed all-in-one social commerce software continues to build a strong team in SEA, seizing upon this era of social distancing

SINGAPORE, March 10, 2022 /PRNewswire/ -- SleekFlow , an Alibaba-backed SaaS start-up, has been grasping the global trend of social commerce and actively expanding in terms of hiring and clients' profile across coun...

2022-03-10 10:30 7384

Antengene Announces IND Approval in China for the Phase I Study of ATG-101 (PD-L1/4-1BB Bispecific Antibody) for the Treatment of Solid Tumors and Non-Hodgkin Lymphoma

-  The novel bispecific antibody ATG-101 is Antengene's first in house developed molecule with global rights. -  This approval in China marks the third regulatory clearance granted to ATG-101 globally. -  Upon receiving clearances in Australia and the U.S. in 2021, the Phase I study of ATG-101 ...

2022-03-10 08:52 5039

Transcenta Presented Safety / Tolerability and Preliminary Anti-tumor Activity Data in Gastric and Pancreatic Cancers of TST001 Monotherapy from China Phase I Clinical Trial at the 2022 International Gastric Cancer Congress

SUZHOU, China, March 10, 2022 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development and manufacturing of antibody-based therapeutics, announces that Transcenta has ...

2022-03-10 08:30 4455

Sofwave Medical LTD reports financial results for the full year 2021 with accelerated growth in revenues and gross margin

Revenue increased in 2021 to $21.8M vs. $4.3M in 2020 2021 second-half revenue increased to $11.7M vs. $3.5M in the second half of 2020 Record Q4 2021 revenues of $8.9M Revenue from pulses for the full year 2021 increased to $2.6M TEL AVIV, Israel, March 9, 2022 /PRNewswire/ -- Mr. Lou Scafuri,...

2022-03-09 23:20 2663

New Tough Off-road Contender--GWM TANK300 Arrives Now

BAODING, China, March 9, 2022 /PRNewswire/ -- Recently, according to the 2021 sales report of GWM, GWM TANK300 has an outstanding market share, accounting for more than 50% of the tough off-road market inChina.

2022-03-09 21:59 10622

SOPHiA GENETICS HRD Solution Adopted in Asia Pacific

BOSTON, LAUSANNE, Switzerland and TAIPEI CITY, Taiwan, March 9, 2022 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH) today announced that SOFIVA GENOMICS, which is one of the largest genetic testing companies inTaiwan aiming to provide genetic testing to clinicians, is the first institution inAsia...

2022-03-09 21:57 3321

New Virtual Selling and Coaching Technologies from Bigtincan Allow Organizations to Bring the Metaverse and Web 3.0 Technologies to Sales Teams and Customers

New Features Dramatically Improve Engagement in Virtual Environments  WALTHAM, Mass., March 9, 2022 /PRNewswire/ -- Bigtincan® (ASX:BTH), the global leader in sales enablement automation, today announced the availability of a set of technologies that allow organizations to bring Metaverse and Web...

2022-03-09 21:00 2107

Antengene Announces Five Upcoming Presentations at the 2022 American Association for Cancer Research Annual Meeting

* Posters Showcase Early-Stage Clinical and Preclinical Pipeline. * Focus on ATG-037, ATG-018, ATG-022, ATG-012 and ATG-008. SHANGHAI and HONG KONG, March 9, 2022 /PRNewswire/ -- Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading innovative, global biopharmaceutical company ...

2022-03-09 20:00 5212

InsurTech Carrot Distributes Distance-based Auto Insurance To More Than Half A Million Consumers

SEOUL, South Korea, March 9, 2022 /PRNewswire/ -- A leading insurance technology platform Carrot General Insurance Corp. ("Carrot" or the "Company"), today announced that it has sold more than 500 thousand policies for its flagship pay-per-mile usage-based (UBI) auto insurance program. Having ...

2022-03-09 19:57 5414

New IBM Cybersecurity Hub to help Asia Pacific organizations build Cyber resiliency

- IBM Security Command Center in India represents significant investment in security incident response and training for organizations across APAC - Asia was #1 most-targeted region for cyberattacks in 2021, according to IBM Security X-Force Threat Intelligence Index, released today MANILA, Phili...

2022-03-09 19:35 6056

Antengene Announces XPOVIO® Approved by the TGA in Australia for the Treatment of Relapsed and/or Refractory Multiple Myeloma and Triple Class-Refractory Multiple Myeloma

-  XPOVIO®, in combination with bortezomib and dexamethasone (XBd), gives patients with relapsed and/or refractory multiple myeloma, a new treatment option. -  XPOVIO®, in combination with dexamethasone (Xd), gives patients with triple class refractory multiple myeloma, a new treatment option.  ...

2022-03-09 19:08 4246
1 ... 847848849850851852853 ... 904